1. Home
  2. CLRB vs FLYE Comparison

CLRB vs FLYE Comparison

Compare CLRB & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • FLYE
  • Stock Information
  • Founded
  • CLRB 2002
  • FLYE 2018
  • Country
  • CLRB United States
  • FLYE United States
  • Employees
  • CLRB N/A
  • FLYE N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • FLYE Aerospace
  • Sector
  • CLRB Health Care
  • FLYE Industrials
  • Exchange
  • CLRB Nasdaq
  • FLYE Nasdaq
  • Market Cap
  • CLRB 17.6M
  • FLYE 10.2M
  • IPO Year
  • CLRB N/A
  • FLYE 2024
  • Fundamental
  • Price
  • CLRB $4.98
  • FLYE $0.96
  • Analyst Decision
  • CLRB Hold
  • FLYE
  • Analyst Count
  • CLRB 2
  • FLYE 0
  • Target Price
  • CLRB N/A
  • FLYE N/A
  • AVG Volume (30 Days)
  • CLRB 1.3M
  • FLYE 993.5K
  • Earning Date
  • CLRB 08-12-2025
  • FLYE 08-18-2025
  • Dividend Yield
  • CLRB N/A
  • FLYE N/A
  • EPS Growth
  • CLRB N/A
  • FLYE N/A
  • EPS
  • CLRB N/A
  • FLYE N/A
  • Revenue
  • CLRB N/A
  • FLYE $28,547,111.00
  • Revenue This Year
  • CLRB N/A
  • FLYE N/A
  • Revenue Next Year
  • CLRB N/A
  • FLYE N/A
  • P/E Ratio
  • CLRB N/A
  • FLYE N/A
  • Revenue Growth
  • CLRB N/A
  • FLYE N/A
  • 52 Week Low
  • CLRB $4.36
  • FLYE $0.33
  • 52 Week High
  • CLRB $94.50
  • FLYE $7.30
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 33.34
  • FLYE N/A
  • Support Level
  • CLRB $6.50
  • FLYE N/A
  • Resistance Level
  • CLRB $8.30
  • FLYE N/A
  • Average True Range (ATR)
  • CLRB 1.42
  • FLYE 0.00
  • MACD
  • CLRB -0.66
  • FLYE 0.00
  • Stochastic Oscillator
  • CLRB 1.63
  • FLYE 0.00

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About FLYE Fly-E Group Inc. Common Stock

Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.

Share on Social Networks: